Mate your calling a 7 million market cap with 5 million in funding on a company about to pass GLP, start phase 1 first human trials and clear safety with Walter Reed results announced providing the company with the opportunity to gain access to non dilutive funding of upto 20 million dollars
Please fundamentals are all there. If they wanted to raise they would have last week. They have the runway to phase 2. Calling a 7 million market cap with 5 million in funding is plain stupid with the indications of the drug and they own the drug class. Go do some proper research
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)